Photo credit: Carmen Yahchouchi/MSF Letter Letter | 11 November 2024 Diabetes MSF comments on replies from Eli Lilly, Novo Nordisk and Sanofi on access to insulin
Letter | 17 October 2024 Diagnostics Open Letter: Danaher and Cepheid, over 200,000 people are saying it’s Time for $5 and seek your response 4 min
Letter | 23 September 2024 Diabetes Open letter to Eli Lilly on barriers to accessing diabetes medicines
Letter | 23 September 2024 Diabetes Open letter to Sanofi on barriers to accessing diabetes medicines
Letter | 23 September 2024 Diabetes Open letter to Novo Nordisk on barriers to accessing diabetes medicines
